172 related articles for article (PubMed ID: 3954815)
1. Influence of tasuldine and acetylcysteine on mucociliary clearance in patients with chronic airways obstruction.
Dorow P; Weiss T; Felix R; Köhler M
Arzneimittelforschung; 1986; 36(1):131-3. PubMed ID: 3954815
[TBL] [Abstract][Full Text] [Related]
2. Effect of N-acetylcysteine in subjects with slow pulmonary mucociliary clearance.
Todisco T; Polidori R; Rossi F; Iannacci L; Bruni B; Fedeli L; Palumbo R
Eur J Respir Dis Suppl; 1985; 139():136-41. PubMed ID: 3862607
[TBL] [Abstract][Full Text] [Related]
3. Effect of oral N-acetylcysteine on mucus clearance.
Millar AB; Pavia D; Agnew JE; Lopez-Vidriero MT; Lauque D; Clarke SW
Br J Dis Chest; 1985 Jul; 79(3):262-6. PubMed ID: 3893512
[TBL] [Abstract][Full Text] [Related]
4. [Effect of lysine stepronin salts on mucociliary clearance].
Olivieri D; Bernareggi V; Quitadamo M
Arch Monaldi; 1985; 40(5-6):211-7. PubMed ID: 3843171
[No Abstract] [Full Text] [Related]
5. The effect of tasuldine, a bronchosecretolytic agent, on mucus rheology and clearability and the interaction with acetylcholine in ferrets.
App EM; Tomkiewicz RP; Hahn HL; Engler H; Vergin H; King M
Pulm Pharmacol Ther; 1997; 10(5-6):271-6. PubMed ID: 9778490
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the activity of the carbocysteine-sobrerol combination on mucus spinnability.
Distefano SM; Palermo F; Crimi N; Mistretta A; Pamparana F; Messa A
Int J Clin Pharmacol Res; 1988; 8(1):31-5. PubMed ID: 3284830
[TBL] [Abstract][Full Text] [Related]
7. N-Acetylcysteine and mucociliary activity in mammalian airways.
Iravani J; Melville GN; Horstmann G
Arzneimittelforschung; 1978; 28(2):250-4. PubMed ID: 580387
[TBL] [Abstract][Full Text] [Related]
8. [Modification of mucociliary clearance by a combination of theophylline with ambroxol and of ambroxol in monotherapy].
Dorow P; Weiss T
Arzneimittelforschung; 1988 Jun; 38(6):828-30. PubMed ID: 3052462
[TBL] [Abstract][Full Text] [Related]
9. Effect of myrtol standardized and other substances on the respiratory tract: ciliary beat frequency and mucociliary clearance as parameters.
Begrow F; Böckenholt C; Ehmen M; Wittig T; Verspohl EJ
Adv Ther; 2012 Apr; 29(4):350-8. PubMed ID: 22477544
[TBL] [Abstract][Full Text] [Related]
10. [Mucociliary clearance in patients with chronic obstructive bronchopneumopathy: study made with millimicrospheres of albumin labeled with 99mTc].
Banfi F; Camisasca E; Salvotelli V; Borasi G; Bertoli L
Arch Monaldi; 1982; 37(1-2):71-80. PubMed ID: 7187728
[No Abstract] [Full Text] [Related]
11. [Mucolytics in acute and chronic respiratory tract disorders. II. Uses for treatment and antioxidant properties].
Kupczyk M; Kuna P
Pol Merkur Lekarski; 2002 Mar; 12(69):248-52. PubMed ID: 12053601
[TBL] [Abstract][Full Text] [Related]
12. [Regional mucociliary clearance in patients with small-airways disease (author's transl)].
Weiss T; Dorow P; Felix R
Prax Klin Pneumol; 1981 Jul; 35(7):327-30. PubMed ID: 7345429
[No Abstract] [Full Text] [Related]
13. Drug effects on mucociliary function.
Pavia D; Sutton PP; Lopez-Vidriero MT; Agnew JE; Clarke SW
Eur J Respir Dis Suppl; 1983; 128 (Pt 1)():304-17. PubMed ID: 6137400
[TBL] [Abstract][Full Text] [Related]
14. [Optimizing of therapy with theophylline preparations in obstructive respiratory diseases. 4. Effect of theophylline on mucociliary clearance and maximal inspiratory mouth occlusion pressure].
Schmidt G; Ranke C; Creutzig H; Oellerich M; Sybrecht GW
Prax Klin Pneumol; 1983 Apr; 37(4):154-60. PubMed ID: 6866926
[No Abstract] [Full Text] [Related]
15. The pharmacologic approach to airway clearance: mucoactive agents.
Rubin BK
Paediatr Respir Rev; 2006; 7 Suppl 1():S215-9. PubMed ID: 16798570
[TBL] [Abstract][Full Text] [Related]
16. [Mucolytics in acute and chronic respiratory tract disorders. I. Pathophysiology and mechanisms of action].
Kupczyk M; Kuna P
Pol Merkur Lekarski; 2002 Mar; 12(69):245-7. PubMed ID: 12053600
[TBL] [Abstract][Full Text] [Related]
17. N-acetylcysteine inhibits Na+ absorption across human nasal epithelial cells.
Rochat T; Lacroix JS; Jornot L
J Cell Physiol; 2004 Oct; 201(1):106-16. PubMed ID: 15281093
[TBL] [Abstract][Full Text] [Related]
18. Mucoactive agents for airway mucus hypersecretory diseases.
Rogers DF
Respir Care; 2007 Sep; 52(9):1176-93; discussion 1193-7. PubMed ID: 17716385
[TBL] [Abstract][Full Text] [Related]
19. Mucolytic agents and mucociliary activity.
Gunnarsson M; Hybbinette JC; Mercke U
Rhinology; 1984 Dec; 22(4):223-31. PubMed ID: 6151739
[TBL] [Abstract][Full Text] [Related]
20. Influence of ambroxol on tracheobronchial clearance in simple chronic bronchitis.
Ericsson CH; Juhász J; Mossberg B; Philipson K; Svartengren M; Camner P
Eur J Respir Dis; 1987 Mar; 70(3):163-70. PubMed ID: 3569448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
